Company profile: eMolecules
1.1 - Company Overview
Company description
- Provider of a free chemical structure search engine to search and order over 50M unique structures and 76M part numbers, including 4.5M building blocks and 20.3M screening compounds from 210+ suppliers. Offers compound reformatting, inventory management and global distribution, a virtual chemical space of over 4.9 trillion compounds for drug discovery, and structure data downloads for virtual screening, lead optimization, and cheminformatics.
Products and services
- Building Blocks: A custom-synthesizable catalog to search and order over 4.5 million unique chemical building blocks and advanced intermediates, with items readily available or made-to-order
- Chemical Structure Search Engine: An industrial-grade platform to search and order from over 50 million unique chemical structures and 76 million part numbers, aggregating building blocks and screening compounds from over 210 global suppliers
- Screening Compounds: A research-grade collection granting access to over 20.3 million unique screening compounds from more than 15 suppliers, enabling construction and replenishment of compound libraries
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to eMolecules
AssistRx
HQ: United States
Website
- Description: Provider of healthcare IT solutions for the specialty pharmaceutical distribution channel, including iAssist for streamlined specialty therapy initiation (e-consent, e-prescribing, real-time e-prior authorization), patient solutions with integrated reimbursement and clinical support, e-support services, non-commercial pharmacy services, the CoAssist direct-to-patient pharmacy, and Directive Analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AssistRx company profile →
BioPharmics
HQ: United States
Website
- Description: Provider of AI-based drug design and modeling tools for researchers and scientists, offering algorithms and software for computational drug design, including 2D-to-3D ligand conversion, conformer generation, molecular docking, molecular similarity, binding affinity prediction, and real-space modeling of ligand ensembles in X-ray density maps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioPharmics company profile →
Forte Research
HQ: United States
Website
- Description: Provider of clinical and translational research management software, offering OnCore and Clinical Conductor CTMS for operational, financial, analytics, regulatory, and recruitment needs at academic medical centers, cancer centers, health systems, hospitals, and research sites; plus Advarra eReg, eSource + EDC, eConsent, and Secure Document Exchange for compliant data capture and secure e-regulatory document workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forte Research company profile →
Emerald Cloud Lab
HQ: United States
Website
- Description: Provider of technology platforms for biotechnology innovation, including ECL Command Center for remote experiment design and execution; ECL Constellation for organizing data into a knowledge graph; access to 200+ automated lab instruments (HPLC, Mass Spectrometry, NMR); and 4,500+ data visualization, analysis, and simulation functions via point-and-click or direct command entry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerald Cloud Lab company profile →
Asimov
HQ: United States
Website
- Description: Provider of AI-enabled synthetic biology platforms and tools for designing and manufacturing next-generation therapeutics, offering the CHO Edge System for biologics production, LV Edge System for lentiviral production, a Genetic Design Platform, Cello for computer-aided genetic design, and the ASKE AI design engine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asimov company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for eMolecules
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to eMolecules
2.2 - Growth funds investing in similar companies to eMolecules
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for eMolecules
4.2 - Public trading comparable groups for eMolecules
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →